One Lambda
One Lambda was founded in 1984 by Dr. Paul Terasaki, a pre-eminent researcher in the field of transplantation. From its inception, the company has been at the forefront of transplant diagnostics and has been first to market with a number of cutting edge solutions that have helped laboratories and clinicians meet the ever increasing demands for high quality data and improved patient outcomes.
In July of 2012, One Lambda was acquired by Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific's global presence and extensive customer channel network have enhanced our ability to deliver our products and services to HLA laboratories worldwide. We remain committed to improving the quality of life of transplant patients and their families by developing and producing innovative, high quality HLA products for the clinical and research segments of the transplant community.

The future is an opportunity to apply the traditions of quality and innovation to rapidly advancing technology. With a core market firmly established, we look beyond the familiar, researching ways to touch not only histocompatibility, but all of transplantation.

For details visit website

For further infornmation on our territory representation please contact us.